Exhibit 99.1 Natural Health Trends Reports Third Quarter 2024 Financial Results – Total net sales increased sequentially and year-over-year during the third quarter of 2024 – Improved operating bottom line for three consecutive quarters – Generated cash flows from operations before 2017 Tax Act installment of $514,000 during the first nine months of 2024 – Declared a quarterly cash dividend of $0.20 per share HONG KONG – October 30, 2024 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling ...

Natural Health Trends Corp. (NHTC) reported earnings per share (EPS) of 2 cents in the second quarter of 2024 against the year-ago loss of 2 cents per share. Revenues in Detail Natural Health registered revenues of $10.5 million in the second quarter, down 0.3% year over year. Lower revenues from the majority of the segments dampened the topline. Segment Details Natural Health derives revenues from three segments — Primary Reporting Segment, China and Russia and Kazakhstan. For the quarter under review, Pri ...

Natural Health Trends Corp. (NASDAQ:NHTC) Q2 2024 Earnings Conference Call July 31, 2024 11:30 AM ET Company Participants Michelle Glidewell - IR Chris Sharng - President Scott Davidson - SVP & CFO Conference Call Participants Operator Greetings, and welcome to the Natural Health Trends Corp. Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Commission File Number: 001-36849 NATURAL HEALTH TRENDS CORP. (Exact name of registrant as specified in its charter) Delawa ...

Exhibit 99.1 Natural Health Trends Reports Second Quarter 2024 Financial Results – Total net sales were flat compared to the second quarter of 2023; first year-over-year increase in Hong Kong net sales since the first quarter of 2023 – Cash flows from operations before 2017 Tax Act installment were positive for second consecutive quarter – Declared a quarterly cash dividend of $0.20 per share HONG KONG – July 31, 2024 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce comp ...

Core Viewpoint - Natural Health Trends Corp. will report its financial results for the second quarter of 2024 on July 31, 2024, at 9:00 a.m. Eastern Time, followed by a conference call at 11:30 a.m. Eastern Time to discuss the results [1]. Group 1: Financial Reporting - The financial results for the second quarter ended June 30, 2024, will be announced on July 31, 2024 [1]. - A conference call will be hosted by the President and CFO of Natural Health Trends to discuss the financial results on the same day [1]. Group 2: Conference Call Details - The conference call is scheduled for July 31, 2024, at 11:30 a.m. Eastern Time [2]. - Dial-in numbers for the conference call include 1-877-407-0789 for domestic and 1-201-689-8562 for international participants [2]. - A replay of the call will be available from 2:30 p.m. Eastern Time on July 31, 2024, until 11:59 p.m. Eastern Time on August 7, 2024 [2]. Group 3: Company Overview - Natural Health Trends Corp. is an international direct-selling and e-commerce company operating in Asia, the Americas, and Europe [1]. - The company markets premium quality personal care products under the NHT Global brand [1].

Core Viewpoint - Natural Health Trends Corp. will report its financial results for the second quarter of 2024 on July 31, 2024, at 9:00 a.m. Eastern Time, followed by a conference call at 11:30 a.m. Eastern Time to discuss these results [1]. Financial Results Announcement - The financial results for the second quarter ended June 30, 2024, will be announced on July 31, 2024 [1]. - The conference call to discuss the financial results will take place on the same day at 11:30 a.m. Eastern Time [1]. Conference Call Details - Date: July 31, 2024 [2]. - Time: 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time [2]. - Dial-in numbers: 1-877-407-0789 (Domestic) and 1-201-689-8562 (International) [2]. - Conference ID: 13746911 [2]. - Replay availability from 2:30 p.m. Eastern Time on July 31, 2024, until 11:59 p.m. Eastern Time on August 7, 2024 [2]. Company Overview - Natural Health Trends Corp. is an international direct-selling and e-commerce company operating in Asia, the Americas, and Europe [1]. - The company markets premium quality personal care products under the NHT Global brand [1].

Core Viewpoint - Zacks Investment Research has initiated coverage of Natural Health Trends Corp. (NHTC) with a "Neutral" recommendation, reflecting a mixed outlook for the company amid industry challenges [1] Company Overview - Natural Health Trends, operating as NHT Global, is based in Delaware with corporate headquarters in Hong Kong, focusing on marketing personal care, wellness, and quality-of-life products through an Internet-based direct selling model [1] Financial Performance - The company reported an 11% quarterly increase in order volumes and modest year-over-year growth, despite a slight dip in revenues [2] - Positive cash flow is maintained, supported by sound financial strategies, including a $0.20 dividend per share [2] - The company has a modest market capitalization of $79 million, indicating a low valuation relative to industry standards [4] Strategic Initiatives - NHT Global is strategically expanding into the Indian market, showcasing substantial growth figures and new product launches [2] - The company is adapting to global e-commerce trends, positioning itself to benefit from increasing digital consumerism and demand for personalized shopping experiences [2][3] Market Positioning - Natural Health Trends' stock has outperformed industry peers and the broader market over the past year, presenting a compelling entry point for investors [4] - The company's positive momentum in orders and robust financial management are key factors for future growth [3]

Financial Data and Key Metrics Changes - Total revenue for Q1 2024 was $11 million, an 8% decrease from $11.9 million in Q1 2023, attributed to an increase in deferred revenue of $1 million [11] - Gross profit margin declined slightly to 73.4% from 74.5% in the prior year due to increased product costs [12] - Net income for Q1 2024 was $188,000 or $0.02 per diluted share, compared to $257,000 or $0.02 per diluted share in Q1 2023 [13] Business Line Data and Key Metrics Changes - The active member base decreased to 31,620 at March 31, down from 32,410 at December 31, and down 18% from 38,330 at March 31 last year [11] - Commissions expense as a percentage of net sales decreased to 41% from 42.1% in the prior year quarter [12] Market Data and Key Metrics Changes - India achieved year-over-year triple-digit growth driven by the launch of a new product and a robust calendar of events [9] - The company resumed product road shows, connecting with over 600 participants eager to learn about new products [8] Company Strategy and Development Direction - The company emphasizes innovation, customer satisfaction, leadership development, and operational efficiency as part of its strategy [7] - The year-long achiever bonus program and the train the trainer program have been well received, indicating a focus on building loyal product consumers and future leaders [7] Management Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the operating landscape and its potential impact on the business, noting encouraging signs pointing in the right direction [14] - The company remains committed to prudent financial management and improving operational efficiencies [15] Other Important Information - Total cash, cash equivalents, and marketable securities were $54.4 million at March 31, down from $56.2 million at December 31 [14] - The Board of Directors declared a quarterly cash dividend of $0.20 per share, payable on May 24 to stockholders of record as of May 14 [14] Q&A Session Summary No Q&A session was held for this event [16]

Financial Performance - Net sales for the three months ended March 31, 2024, were $10,951,000, a decrease of 7.7% compared to $11,861,000 for the same period in 2023[15]. - Gross profit for the first quarter of 2024 was $8,039,000, down from $8,830,000 in the same quarter of 2023, reflecting a decline of approximately 9.0%[15]. - Net income for the three months ended March 31, 2024, was $188,000, compared to $257,000 for the same period in 2023, indicating a decrease of approximately 26.9%[15]. - The company reported a comprehensive income of $36,000 for Q1 2024, significantly lower than $157,000 in Q1 2023, reflecting a decline of about 77.1%[18]. - The company reported total net sales of $10.951 million for the three months ended March 31, 2024, down from $11.861 million in the same period of 2023, representing a decrease of approximately 7.66%[81]. - The primary reporting segment generated net sales of $10.466 million for the three months ended March 31, 2024, compared to $11.331 million in the prior year[81]. - In Q1 2024, net sales were $11.0 million, a decrease of $910,000 or 8% compared to $11.9 million in Q1 2023[108]. - Hong Kong net sales decreased by $499,000 or 5% year-over-year, primarily due to changes in deferred revenue, which increased by $1.0 million in Q1 2024[108]. Assets and Liabilities - Total current assets decreased to $62,733,000 as of March 31, 2024, down from $64,229,000 on December 31, 2023, representing a decline of approximately 2.3%[13]. - Total liabilities increased to $28,269,000 as of March 31, 2024, compared to $27,491,000 on December 31, 2023, marking an increase of approximately 2.8%[13]. - Stockholders' equity decreased to $39,370,000 as of March 31, 2024, down from $41,600,000 at the end of 2023, representing a decline of about 5.4%[13]. - Cash and cash equivalents decreased to $25,825,000 as of March 31, 2024, down from $56,178,000 on December 31, 2023, a decline of approximately 54.0%[13]. - The company had $25.862 million in cash, cash equivalents, and restricted cash at the end of the period, a decrease from $66.648 million at the end of the previous year[25]. - Working capital as of March 31, 2024, was $41.9 million, a decrease of $2.4 million compared to December 31, 2023[115]. - The ratio of current assets to current liabilities was 3.0 to 1.0 as of March 31, 2024[115]. Expenses - Total operating expenses decreased to $8,404,000 in Q1 2024 from $9,224,000 in Q1 2023, a reduction of about 8.9%[15]. - Selling, general and administrative expenses decreased to $3.9 million for the three-month period ended March 31, 2024, compared to $4.2 million in the same period a year ago, primarily due to lower employee-related costs and professional fees[111]. - The company experienced a decrease in share-based compensation expenses, which were $37 million for the three months ended March 31, 2024, compared to $46 million in the prior year[25]. - Commissions expense represented 41.0% of net sales in Q1 2024, compared to 42.1% in Q1 2023, attributed to lower weekly commissions outside of Hong Kong[110]. Cash Flow - The company reported a net cash provided by operating activities of $549 million, a significant improvement compared to a net cash used of $696 million in the prior year[25]. - Cash provided by operations was $549,000 for the first three months of 2024, an improvement from cash used in operations of $696,000 for the same period in 2023, reflecting increased order volume and better management of operating costs[116]. - Total cash, cash equivalents, and marketable securities decreased by $1.7 million from December 31, 2023, to $54.4 million as of March 31, 2024, due to dividends paid during the first three months of 2024[115]. - Cash flows used in investing activities totaled $28.5 million for the first three months of 2024, primarily for purchasing marketable securities[116]. Dividends and Stock Repurchase - The company declared dividends of $0.20 per share, totaling $2,303,000 for the quarter[21]. - Cash dividends of $0.20 per common share were declared and paid, totaling $2.3 million for each quarter in 2024 and 2023[73]. - As of March 31, 2024, $21.9 million of the $70.0 million stock repurchase program remained available for future purchases[74]. - As of March 31, 2024, $21.9 million of the $70.0 million stock repurchase program remained available for future purchases[118]. Market and Operations - Active members decreased to 31,620 as of March 31, 2024, from 32,410 at December 31, 2023, and 38,330 at March 31, 2023[88]. - Approximately 95% of net sales are generated from subsidiaries located outside the Americas, with the Hong Kong subsidiary accounting for 84% of net sales in the latest fiscal quarter[89]. - The company operates an e-commerce direct selling platform in Hong Kong, with substantial revenues derived from sales to members in China[90]. - The business environment in China remains challenging due to ongoing government scrutiny and negative social media sentiment towards health product companies[93]. - The company has resumed in-person member events in China, Hong Kong, and Macau since Q1 2023, indicating a gradual normalization of operations[94]. - The company plans to continue adapting its marketing programs to overcome physical restrictions and is hopeful for sustained recovery in operations[94]. Tax and Deferred Revenue - The effective income tax rate for the three months ended March 31, 2024, includes estimates for foreign income inclusions, with a total income taxes payable of $9,000,000 related to the repatriation tax[62]. - Deferred revenue increased to $5.5 million as of March 31, 2024, from $4.4 million at the end of 2023, primarily due to $4.2 million of cash received for unshipped product orders[40]. - As of March 31, 2024, deferred revenue was $7.2 million, consisting of $5.5 million in unshipped product orders and $1.7 million in auto ship advances[108]. Investments and Future Plans - The company aims to invest in Greater China and other markets, focusing on establishing manufacturing capabilities and increasing brand awareness[121]. - The company plans to reapply for a direct selling license in China when circumstances are favorable, which could incrementally benefit existing business operations[90].